Pharmaceutical Executive-02-01-2013

Pharmaceutical Executive

Country Report: Australia

February 01, 2013

Country Report

0

0

In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is globally: the country is dealing with patent cliffs, companies are cutting back staff, an ageing population forces the government to rethink healthcare expenditures, and big originator companies are reforming.

Fortuity and the First Amendment

February 01, 2013

Column

0

0

Caronia decision shows the staying power of Sorrell v. IMS Health.

In Cancer, Process Drives Progress

February 01, 2013

From the Editor

0

0

Today's most important public health story is the advance in our understanding of the biology of cancer, writes Pharm Exec Editor-in-Chief William Looney.

Oncology: Pathways to Progress

February 01, 2013

Features

0

0

Pharm Exec recently convened a cross-section of industry experts to review current and pending efforts to turn great science into good oncology practice.

Pharmaceutical Executive Digital Edition - February 2013

February 01, 2013

Issue PDF

0

0

2013 Oncology Practice Roundtable